GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP) (Q16AH6)

Analyse AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q16AH6
Type
protein
Length
532 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x2931D84e23977a8d0Ac1b95de99228F1cC0Bc62d
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
UniProt
Q16AH6
Pockets
2 · best druggability 0.71

Structure

1 distinct chain · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP)protein53231% helix, 26% strandQ16AH6

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16310.710.7957empty
2520.290.7611empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.